Skip to main content
. 2013 Oct 2;34(1):118–125. doi: 10.1038/jcbfm.2013.171

Figure 5.

Figure 5

Rate constants after treatments with different doses of carbidopa (A and C) or different enzymatic inhibitors (B and D). Time–activity curves and plasma–input curves were fitted in a two-tissue compartment model (2TCM), rendering Kacc and k3. Data are depicted as mean±s.e.m. (A) Carbidopa does not influence Kacc. (B) There is no significant effect of inhibition of tryptophan hydroxylase (TPH) by para-chlorophenylalanine (PCPA), aromatic amino acid decarboxylase (AADC) by NSD 1015, or Trp depletion on Kacc, although a trend towards a decrease is seen after PCPA treatment. (C) Carbidopa does not influence k3. (D) Only PCPA decreases k3 significantly. *P<0.05.